IP Library › Granted Patent US 7,427,666
Granted Patent B2
US 7,427,666 · App. 11/602,835 · Granted Sep 23, 2008

Antibody directed against a ubiquitin-specific protease occurring in the brain

Assignee: Eisai R&D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,427,666
App. No.
11/602,835
Granted
Sep 23, 2008
Kind
B2
Abstract

A ubiquitin-specific protease occurring in the brain and a DNA encoding it, which are useful for research on the molecular mechanism of the neuroplasticity expression and so on.

Claims (1)

1. An isolated antibody directed to a peptide consisting of the amino acid sequence of the amino acid numbers 1022 to 1036 in the amino acid sequence of SEQ ID NO: 2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019235/0487 →
Priority Claims (1)
JP 2001-330339 · Oct 29, 2001 · national
Continuity (2)
Division 1049402600
Related Publication 20070072269A1 · Mar 29, 2007